Results 241 to 250 of about 225,854 (265)

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Ronald F Van Vollenhoven, Roy Fleischmann, Eun Bong Lee   +2 more
exaly  

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

New England Journal of Medicine, 2020
Andrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan   +2 more
exaly  

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

New England Journal of Medicine, 1996
James R O'Dell, J R O'Dell, O'Dell James R   +2 more
exaly  

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

New England Journal of Medicine, 2004
Jonathan Edwards, Anna Filipowicz-Sosnowska, Paul Emery   +2 more
exaly  

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

New England Journal of Medicine, 1997
Larry W Moreland, Michael H Schiff, Roy Fleischmann   +2 more
exaly  

RHEUMATOID FACTORS AND THE ETIOLOGY OF RHEUMATOID ARTHRITIS^*

Annals of the New York Academy of Sciences, 1965
H H, Fudenberg, E C, Franklin
openaire   +2 more sources

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New England Journal of Medicine, 2001
Ernest Choy, G S Panayi
exaly  

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis

New England Journal of Medicine, 1978
Peter Stastny, P Stastny, Stastny Peter   +2 more
exaly  

Rheumatoid Factor ‐ Autospecificity or Isospecificity?

Vox Sanguinis, 1965
K, AHO, M, HARBOE, K, SIEVERS
openaire   +2 more sources

STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

New England Journal of Medicine, 2007
Elaine F Remmers, Annette T Lee, Timothy W Behrens   +2 more
exaly